Go to the list of all blogs
Allana's Avatar
published in Blogs
Sep 01, 2026
SQM Stock Climbs +17.8% Over 30 Days Following Strong Q2 Results

SQM Stock Climbs +17.8% Over 30 Days Following Strong Q2 Results

Key Takeaways

  • SQM shares climbed roughly 17.8% over the last 30 days, from about $67.06 to approximately $79, driven by a strong second-quarter earnings report.
  • Q2 2026 results exceeded expectations, with revenue of $2.47 billion, net income of $660 million, and adjusted EPS of $2.31.
  • A sharp rebound in lithium prices and record sales volumes powered the quarter, while iodine delivered a second consecutive record result.
  • Over the trailing quarter, the stock traced a volatile path—easing from May highs before recovering on upbeat results.
  • Lithium demand from electric vehicles and energy storage, commodity pricing, and the Codelco partnership remain central to the investment case.

Understanding SQM's Business and Market Position

Sociedad Química y Minera de Chile S.A. operates as a Santiago-based producer of specialty chemicals and minerals, with activities across lithium, iodine, specialty plant nutrition, potassium, and industrial chemicals. The company draws these resources from high-quality salt brine deposits and caliche ore, centered on its Salar de Atacama operation in Chile, which stands among the world's lowest-cost lithium sources.

Lithium forms the most closely followed segment, providing battery-grade lithium carbonate and hydroxide for electric vehicles and energy-storage systems. SQM develops lithium through its Novandino joint venture with Chilean state-owned Codelco, in addition to a hard-rock lithium joint venture in Australia and refining assets in China. Beyond lithium, SQM ranks as a leading global supplier of iodine for X-ray contrast media and of specialty potassium and sodium nitrate fertilizers. Investors track the stock for its ties to the energy transition, its diversified commodity exposure, and its low-cost production base. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Stock Movement: Last 30 Days Versus the Quarter

Over the last 30 days, SQM advanced from a closing price of about $67.06 to roughly $79, an increase of approximately 17.8%. The move was not entirely steady: the stock rallied through mid-August after earnings, reached an intraday peak near $84.50 on August 21, and then consolidated modestly toward the end of the period.

The trailing quarter showed more volatility. Earlier in the quarter, SQM traded near its 52-week high of $98.00 reached in May, before selling pressure pulled the stock into the $65–$67 range by mid-July. The earnings-driven rebound that followed narrowed the decline, leaving the stock roughly 8% lower over the trailing three months measured from late May. This pattern reflects a repricing as lithium fundamentals improved after a stretch of oversupply-related weakness.

Key Drivers Behind the 30-Day Gains

The main catalyst came from the company's second-quarter 2026 earnings report, released on August 18. SQM posted revenue of $2.47 billion—up about 137% year over year and roughly 10% above consensus—alongside net income of $660 million and adjusted EPS of $2.31, comfortably ahead of the approximately $2.04 estimate. Adjusted EBITDA more than quadrupled year over year.

Lithium stood out. Segment revenue climbed roughly 300% year over year to about $1.78 billion, supported by record sales volume above 84,000 metric tons of lithium carbonate equivalent. The realized price at the Novandino joint venture reached about $21.80 per kilogram, up roughly 23% from the prior quarter and about 160% higher than a year earlier. Management also raised its full-year global lithium demand forecast to more than 2.1 million metric tons.

Iodine added further support, posting a second straight record quarter with average realized prices near $73.40 per kilogram. The combination of stronger-than-expected results and a more constructive lithium outlook outweighed initial “sell-the-news” profit-taking and valuation concerns that briefly pressured the shares after the report. From what I see, this earnings beat provided clear confirmation of improving fundamentals.

Broader Quarterly Trends and Influences

The wider quarterly trend was shaped by the lithium price cycle. Through the spring, SQM benefited from a rebound in lithium markets as demand from battery storage and electric vehicles outpaced expectations. However, lingering oversupply worries and profit-taking pushed the stock from its May peak into the mid-$60s by July.

The recovery that followed rested on improving fundamentals: firmer realized lithium prices, record volumes, and resilient iodine pricing. Progress and growing clarity around the Codelco joint venture also helped ease regulatory uncertainty, while the company's low-cost Salar de Atacama asset supported its competitive position. The net effect was a quarter of wide swings that ended with the stock regaining much—but not all—of its earlier losses.

What Investors Should Watch Next

Looking ahead, the most important factors for SQM include the trajectory of lithium prices and demand, particularly from electric-vehicle and battery-storage markets. Third-quarter results are scheduled for November 2026, and investors will focus on realized pricing, sales volumes, and any updates to full-year lithium demand and production guidance.

Other key variables include iodine supply dynamics—management has indicated third-party supply could increase into year-end—as well as the terms and execution of the Codelco joint venture, Chilean royalty and regulatory policies, and broader macroeconomic conditions, including demand from China. Competitive supply from peers such as Albemarle (ALB) will also influence the pricing environment. These factors will shape sentiment without guaranteeing any particular outcome. I’m watching this closely as the Codelco partnership developments unfold.

Exploring Systematic Strategies with AI

In my own research process, I occasionally review Tickeron’s Trending AI Robots to compare algorithmic approaches across different timeframes and market conditions. The page highlights top-performing bots that monitor thousands of tickers, allowing a clearer view of how systematic strategies align with names like SQM and broader sector trends. This helps round out fundamental analysis without replacing it.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SQM

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


SQM in upward trend: 10-day moving average broke above 50-day moving average on August 19, 2026

The 10-day moving average for SQM crossed bullishly above the 50-day moving average on August 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 05, 2026. You may want to consider a long position or call options on SQM as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SQM just turned positive on July 29, 2026. Looking at past instances where SQM's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

SQM moved above its 50-day moving average on August 14, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SQM advanced for three days, in of 301 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 270 cases where SQM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SQM moved out of overbought territory on August 25, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where SQM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for SQM moved below the 200-day moving average on August 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SQM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SQM broke above its upper Bollinger Band on August 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.577) is normal, around the industry mean (6.900). P/E Ratio (16.261) is within average values for comparable stocks, (38.572). Projected Growth (PEG Ratio) (0.365) is also within normal values, averaging (2.397). Dividend Yield (0.013) settles around the average of (0.019) among similar stocks. P/S Ratio (3.356) is also within normal values, averaging (66.380).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SQM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 12.02B. The market cap for tickers in the group ranges from 47 to 225.65B. LIN holds the highest valuation in this group at 225.65B. The lowest valued company is GTBT at 47.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -1%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 5%. STDN experienced the highest price growth at 35%, while LOOP experienced the biggest fall at -22%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was 46%. For the same stocks of the Industry, the average monthly volume growth was -11% and the average quarterly volume growth was 18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 57
Price Growth Rating: 51
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
SQM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a producer of potassium nitrate and iodine chemicals

Industry ChemicalsSpecialty

Profile
Details
Industry
Chemicals Agricultural
Address
El Trovador 4285, 6th Floor
Phone
+56 224252000
Employees
6081
Web
https://www.sqm.com
Interact to see
Advertisement
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
GDDY (GoDaddy) is down more than 17% today because its 2026 revenue outlook and near‑term sales guidance came in below Wall Street expectations, reinforcing worries about slowing growth and intense AI‑driven competition even though Q4 2025 headline results were solid.
For the first half of fiscal 2026, organic net sales and adjusted EPS both declined about 3% year over year and missed analyst expectations, with U.S. spirits and Chinese white spirits particularly weak. Management cut full‑year 2026 guidance again, now expecting organic sales to fall 2–3% and organic operating profit to be flat to up only low single digits, versus a prior outlook of flat to slightly down sales and low‑ to mid‑single‑digit profit growth.
DRVN (Driven Brands) is down more than 36% today because the company disclosed serious errors in its past financial statements, is delaying its Q4 2025 earnings release, and will have to restate results for the last two fiscal years, which shattered investor confidence and raised concerns about leverage and profitability.
Q4 2025 revenue was strong at about 257–258 million (up roughly 16% year over year and above forecasts), but adjusted EPS was 0.30 versus about 0.31–0.32 expected, and EBITDA of about 101–102 million was a touch below consensus.
Q4 2025 revenue was about 392 million, roughly 10–20% below consensus (around 430–440 million), and EPS came in at −0.44−0.44 versus forecasts near −0.27−0.27 to −0.32−0.32, a more than 60% negative surprise. Results were hit by a roughly 170 million non‑cash impairment plus weaker realized pricing and volumes, driving a large net loss in the quarter despite strong full‑year EBITDA and free cash flow.
AXON surged approximately +17.56% on February 25, 2026, closing at $520.18 versus the prior session's close of $442.51. The primary catalyst was a blowout Q4 2025 earnings report, with adjusted EPS of $2.15 crushing the consensus estimate of approximately $1.67.
CAVA shares surged approximately +25.01% on February 25, 2026, closing near $84.76, up from the prior session's close of $67.80. The primary catalyst was a better-than-expected Q4 fiscal 2025 earnings report, with EPS of $0.04 beating the $0.03 consensus estimate and revenue of ~$274.99M exceeding the $268.04M estimate.
ODD shares plunged approximately 49.21% on February 25, 2026, closing near $14.74, compared to the prior close of approximately $29.02. The primary catalyst was a shock Q1 2026 revenue warning: management guided for a roughly 30% year-over-year revenue decline due to a severe spike in customer acquisition costs (CAC).
MNKD shares collapsed 36.82% on February 25, 2026, closing at $3.50 versus the prior session's close of $5.54 — one of the largest single-day declines in the stock's recent history. The primary catalyst was United Therapeutics' surprise unveiling of Tresmi, a proprietary soft mist inhaler delivering treprostinil, announced during the company's Q4 2025 earnings call.
EOSE shares fell sharply on February 26, 2026, dropping approximately 31% from the prior session's close of $11.13 to around $7.64 in early trading, following a pre-market earnings release. Primary catalyst: Eos Energy reported Q4 2025 non-GAAP EPS of -$0.72, missing analyst consensus estimates by $0.48, a 200%+ negative surprise.
ARRY beat Q4 revenue expectations but showed a sharp year‑over‑year sales decline and a sizeable net loss. Adjusted EBITDA for Q4 badly missed Wall Street estimates, highlighting ongoing margin and cost pressures. 2026 guidance for EPS and EBITDA came in well below analyst forecasts, signaling weaker‑than‑hoped earnings power over the next year.
C3.ai (AI) dropped more than 18% today after delivering a deeply disappointing quarterly report, slashing its revenue outlook, and announcing mass layoffs, which together reinforced doubts about its growth story in an increasingly competitive AI software market.
On the surface, PRCT’s top line still grew: Q4 2025 revenue reached about 76.4 million dollars, up roughly 11.9–12% from the prior year. However, analysts had expected something closer to 94–96 million dollars, so the shortfall of nearly 20% was significant for a high‑growth med‑tech name.
Payoneer Global (PAYO) fell more than 18% today after it missed Wall Street expectations on both Q4 2025 revenue and earnings, and issued softer‑than‑hoped guidance that reinforced concerns about slowing growth and competitive pressure in cross‑border fintech.
Gold, uranium, and rare earth stocks are moving fast in 2026 — and this 15-minute AI Trading Agent is built to move faster. Designed for high-beta Mining & Metals leaders like NEM, LEU, MP, and KGC, it transforms commodity volatility into structured, data-driven opportunity with institutional-grade risk control.